Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target

Class:Id	LiteratureReference:9701357
_displayName	Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
_timestamp	2020-09-26 21:52:52
author	[Person:9667884] Chiarle, Roberto [Person:9701329] Simmons, William J [Person:9701403] Cai, Honjying [Person:9701367] Dhall, Girish [Person:9701399] Zamo, Alberto [Person:3222419] Raz, Regina [Person:9701359] Karras, James G [Person:9027584] Levy, David E [Person:9648424] Inghirami, Giorgio
created	[InstanceEdit:9701293] Rothfels, Karen, 2020-09-26
journal	Nat. Med.
pages	623-9
pubMedIdentifier	15895073
title	Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
volume	11
year	2005
(literatureReference)	[BlackBoxEvent:9701524] STAT3 is phosphorylated downstream of active ALK [Homo sapiens] [Reaction:9712079] ALK mutants bind STAT3 [Homo sapiens] [BlackBoxEvent:9850958] pY-STAT3 dimer translocates to the nucleus downstream of ALK mutants [Homo sapiens] [BlackBoxEvent:9851142] TYK2-dependent STAT1 and STAT3 phosphorylation [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target (9701357)